Transposase-Promoter Amplification for Instrument-Free CRISPR Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing nucleic acid detection methods face trade-offs among sensitivity, specificity, simplicity, and speed, with isothermal amplification methods offering high detection specificity but limited sensitivity in point-of-care settings, and requiring complex instrumentation.
Innovation Solution
A method involving a transposon complex with a transposase and RNA polymerase promoters for isothermal amplification of nucleic acids, combined with CRISPR Cas13 or Cas12-based detection systems, allowing for sensitive and specific nucleic acid detection without heating.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If qPCR approaches are used for nucleic acid detection, then sensitivity is improved, but device complexity and cost increase due to complex instrumentation requirements
Solution Approach 1:
The patent replaces the mechanical/thermal cycling system of qPCR with a biochemical isothermal amplification system. The transposase enzyme performs DNA amplification at constant temperature without requiring thermal cyclers, while CRISPR-Cas13a provides detection through RNA-guided cleavage of reporter molecules. This substitution eliminates complex temperature control instrumentation while maintaining high detection sensitivity.
Solution Approach 2:
The patent introduces CRISPR-Cas13a as an intermediary detection system that converts DNA amplification results into detectable signals. The Cas13a enzyme, guided by CRISPR RNA, specifically binds to amplified target sequences and cleaves fluorescent reporter molecules, generating detectable signals. This intermediary layer enables sensitive detection without requiring complex qPCR instrumentation.
2Device complexity
If isothermal nucleic acid amplification methods are used, then device complexity is reduced, but detection sensitivity is limited
Solution Approach 1:
The patent merges transposase-based isothermal amplification with CRISPR-Cas13a detection into a unified system. The transposase amplifies target DNA at constant temperature, and the CRISPR-Cas13a system simultaneously detects the amplified products with high sensitivity. This combination achieves both instrumentation simplicity and high detection sensitivity by integrating two complementary biochemical systems.
Solution Approach 2:
The patent optimizes multiple parameters to enhance sensitivity: using engineered transposases with improved activity, optimizing CRISPR guide RNA sequences for maximum specificity, adjusting reporter molecule concentrations, and tuning reaction buffer conditions. These parameter optimizations enable the isothermal system to achieve sensitivity comparable to qPCR methods.
3Measurement precision
If multiple sets of primers are used for amplification, then detection specificity is improved, but ease of operation deteriorates due to complex protocols
Solution Approach 1:
The patent extracts the primer design complexity from the amplification process by using transposase-based insertion instead of traditional PCR primers. The transposase naturally recognizes and binds to specific DNA sequences, performing the function of multiple primers simultaneously. This extraction of complexity simplifies the protocol while maintaining high detection specificity through the transposase's sequence-specific binding.
4Reliability
If initial denaturation steps are required for amplification, then detection reliability is improved, but loss of time increases due to extended protocol duration
Solution Approach 1:
The patent changes the temperature parameter from cyclic variation to constant isothermal conditions. The engineered transposase is optimized to function at a specific constant temperature (e.g., 37°C or 50°C), eliminating the need for initial denaturation and thermal cycling steps. This parameter change maintains amplification reliability through the transposase's temperature-optimized catalytic activity while dramatically reducing protocol time.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, sensitive, and specific detection of nucleic acids at femtomolar to attomolar levels without complex instrumentation, suitable for both clinical and basic research settings.
Implementation Method 1
inserting one or more RNA polymerase promoters into the oligonucleotide using the transposase
Implementation Method 2
amplifying the target nucleic acid sequence by generating RNA oligonucleotides comprising the target nucleic acid sequence via transcription from the inserted one or more RNA polymerase promoters
Implementation Method 3
The amplified target nucleic acid may be detected using a CRISPR Cas13-based detection system
Data Source
AI summary
Provided herein are methods and systems for detecting a target nucleic acid sequence. The method comprises contacting an oligonucleotide comprising the target nucleic acid sequence with a transposon complex; inserting one or more T7 RNA promoters into the oligonucleotide using the transposase; and (c) amplifying the target nucleic acid sequence. The transposon complex may comprise a transposase and a transposon sequence comprising one or more T7 RNA promoters. The target nucleic sequence may be amplified by generating RNA oligonucleotides comprising the target nucleic acid sequence via transcription from the inserted one or more T7 RNA promoters. The amplified target nucleic acid may be detected using a CRISPR Cas13-based detection system.